查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1835600

減重手術設備市場（按手術類型、設備類型、技術和最終用戶分類）—2025-2032 年全球預測

Obesity Surgery Devices Market by Procedure Type, Device Type, Technology, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年減重手術設備市場將成長至 82.2 億美元，複合年成長率為 8.15%。

主要市場統計數據
基準年2024年 43.9億美元
預計2025年 47.5億美元
預測年份：2032年 82.2億美元
複合年成長率（%） 8.15%

全面介紹減肥手術設備的現況與策略重要性

減重手術器材處於臨床需求、加速技術應用和不斷發展的醫療服務模式的交會點。過去十年，臨床醫生和器械開發者一直在努力應對不斷變化的優先事項：提高手術安全性和療效、縮短手術時間以及擴大門診就診管道。這些促進因素，加上患者對微創治療方案的需求以及支付方對長期成本控制的日益關注，使得器械策略必須具備明確的臨床差異化和實用的價值提案。

隨著減重護理整合多學科術前最佳化和長期代謝隨訪，臨床路徑日趨成熟。因此，設備設計的重點正從簡單的手術支援轉向端到端的護理支持，強調人體工學、與不斷發展的手術平台的兼容性以及與醫院和門診工作流程的無縫整合。同時，監管審查和對真實世界證據日益成長的期望，促使開發商投資更強大的臨床項目和長期結果追蹤。

綜上所述，這種環境將有利於那些能夠兼顧臨床有效性和營運效率，同時管理供應鏈彈性和報銷複雜性的公司。相關人員在規劃產品藍圖和商業化策略時，需要在證據產生和平台互通性的長期投資與短期應用之間取得平衡。

變革性變革重新定義減重手術設備競爭優勢與臨床路徑

過去幾年，各種變革性變化正在重新定義醫療器材的競爭優勢。機器人技術和先進的視覺化系統已從輔助工具轉變為核心平台，改變了手術的規劃和執行方式。增強的內視鏡技術，包括更強大的吻合器和縫合功能，正在實現更微創的干涉，並為此前選擇有限的患者開闢新的治療途徑。除了這些技術變革之外，植入材料和輸液港系統也得到了改進，旨在降低併發症發生率並簡化再次手術流程。

同時，醫療保健服務模式也在不斷演變，住院時間縮短、手術全期管道最佳化以及支付方降低成本的獎勵，使得手術盡可能轉移到門診手術中心和專科診所。這種轉變需要設備易於小型團隊使用、能夠適應有限的基礎設施，並由高效的供應鏈和滅菌工作流程提供支援。以金額為準的採購模式越來越重視可證明的療效，迫使研發人員將臨床證據策略與經濟終點結合。

創新不再只是關乎設備本身，也關乎其周邊的生態系統。數位健康整合、遠端監控和數據主導的患者選擇正成為硬體進步的重要補充。產業相關人員的策略重點是將這些要素整合成一個緊密結合的解決方案，以改善患者治療效果、降低總治療成本，並支援在不同醫療環境中進行可擴展的部署。

2025年美國關稅變化對供應鏈商業策略與臨床實施動態的累積影響

2025年，美國實施新的或更高的關稅，將對整個減肥設備生態系統產生單獨且累積的影響。先前從海外供應商採購零件和成品的製造商面臨到岸成本上升的局面，這促使他們迅速重新審視籌資策略。為此，一些公司加快了供應商多元化，建立了區域配送中心，並加強了談判，以緩解利潤壓力。這些營運應對措施將影響前置作業時間、庫存策略和資本配置決策。

為了應對關稅帶來的成本壓力，醫院和門診手術中心的採購團隊調整了採購契約，優先考慮那些能夠顯著節省營運成本並降低併發症發生率的設備。結果，擁有強大價值劑量分攤和總護理成本證據的設備供應商在系統級採購組織中佔據了優先地位，而缺乏差異化臨床或經濟價值的產品則面臨採用阻力。隨著時間的推移，由於客戶優先維護核心功能並推遲購買非必需產品，設備的生命週期和升級計劃也發生了變化。

關稅也改變了競爭格局，削弱了低成本國際參與企業的相對優勢，並為本地製造業投資創造了獎勵。隨著企業處理海關分類和文件，監管和合規工作量也隨之增加。展望未來，企業將繼續投資於本地製造能力和與分銷合作夥伴共用關稅風險的合約結構，而付款方和供應商將優先考慮採購彈性和供應商的彈性。

關鍵細分洞察揭示了特定設備和程序的商業機會和差異化策略

將機會細分，可以發現臨床需求、採購週期和創新重點方面有顯著差異。考慮到胃束帶調整術、胃繞道手術和袖狀切除術等手術類型，對器械的要求也有所不同。胃束帶調整術注重植入的壽命和輸液港系統的可靠性；胃旁路手術更注重複雜的吻合和吻合口的完整性；袖狀切除術需要耐用的吻合平台以及在不同組織條件下吻合器性能的穩定性。這些細分領域影響產品開發的重點和開發後監測策略。

按器械類型細分後發現，切割和縫合器械、內視鏡器械、植入和視覺化系統各自擁有不同的臨床和商業性策略。在內視鏡器械領域，縫合和縫合器械的子領域呈現不同的應用軌跡，由臨床醫生技能和手術流程驅動。同樣，諸如帶狀系統和端口系統等植入類別需要持續專注於生物相容性、感染預防和提取物流，從而塑造售後服務和保固制度。

腹腔鏡、開放性手術和機器人手術方法的技術細分導致不同的資本和培訓要求。機器人解決方案，無論是多臂還是單端口配置，通常都需要更高的前期投資和更長的採用曲線，但可以實現更高的精度和新穎的程序方法。最後，門診手術中心、醫院和專科診所（醫院進一步分為私立和公立）的最終用戶細分導致不同的採購週期、採購權限和營運限制。門診中心通常需要高效的輪調和精簡的消毒，私立醫院優先考慮支援廣泛服務線的優質平台，而公立醫院通常優先考慮成本效益和標準化。這種分層細分對於使臨床證據、定價和打入市場策略與每個相關人員的需求保持一致至關重要。

區域洞察突顯了全球市場中不同的採用管道和策略重點

區域動態持續影響減重手術設備的投資重點和採用模式。在美洲，成熟的醫院體系和私人支付環境支援先進視覺化和機器人平台的快速普及。同時，門診手術中心透過高效的排班和縮短患者住院時間，正在擴大其服務人群。設備供應商與大型綜合醫療服務網路之間的夥伴關係，對於試點新技術和收集真實世界證據日益重要。

歐洲、中東和非洲的地區差異性顯而易見。西方體系通常強調嚴格的衛生技術評估和成本效益，要求提供強力的臨床和經濟證明，以便獲得報銷和在系統層面推廣應用。同時，非洲部分地區仍受到基礎設施和勞動力的限制，因此更注重在資源有限的環境下能夠有效運作的耐用、低維護的解決方案。

亞太市場的特點是手術量快速成長、法規差異化以及對機器人和微創平台的大量投資。該地區一些國家正在擴大三級醫療中心的手術能力，並開展培訓計畫以支持複雜的手術。韌性供應鏈、本地化客製化的監管策略以及兼顧文化差異的病人參與，對於在該地區成功且持續地推出產品至關重要。

主要企業強調策略定位洞察技術重點與協作的重要性

產業參與者正朝著不同的策略方向發展，現有的醫療設備製造商專注於整合平台開發和產生監管級證據，而創新挑戰者則專注於利基技術優勢，例如新型縫合機制、縫合方法、單端口機器人解決方案等。競爭差異化越來越依賴將硬體與服務、臨床培訓和數據分析相結合的能力，從而展示更好的結果和簡化的手術全期流程。

設備開發人員、機器人平台提供者和臨床卓越中心之間的合作正在加速臨床應用，從而解決技術和培訓方面的障礙。授權、聯合開發夥伴關係和服務協議正在加速專用設備的開發，同時共用開發風險。此外，投資於全面的上市後監測和真實世界證據收集的公司更有能力滿足付款人的需求，並獲得優先供應商協議。

那些在可視化、吻合和內視鏡系統中注重模組化和互通性的製造商，正獲得尋求長期資本效率的醫院系統的支持，而那些在監管敏捷性和本地化打入市場策略表現優異的公司，則正在快速成長的地區抓住機遇。對於所有參與者而言，將產品藍圖與臨床醫生工作流程和採購實際情況一致，仍然是預測其能否持久應用的最可靠指標。

為行業領導者提供可行的建議，將見解轉化為商業性和臨床效益

首先，優先投資於將設備性能與以患者為中心和事件層面的治療結果聯繫起來的臨床證據。其次，確保設備易於使用、快速更換，並盡量減少對基礎設施的要求，以吸引門診手術中心和專科診所。第三，透過多元化供應商、建立區域庫存緩衝以及考慮本地化製造和組裝以降低關稅和物流風險，增強供應鏈的韌性。

第四，我們追求互通性和模組化，實現與主流視覺化和機器人平台的整合，從而降低客戶轉換成本並提升交叉銷售潛力。第五，我們根據私人醫院、公立醫院和門診病人的需求，客製化培訓計劃、保固模式和服務契約，為不同的最終用戶制定差異化的價值提案。第六，我們積極與付款方和衛生技術評估機構合作，協調證據產生和報銷標準，並探索基於結果共擔風險的創新合約模式。

最後，與臨床領先企業和卓越中心建立夥伴關係，以加速採用、完善程序通訊協定並產生高品質的真實世界數據，這將共同創造廣泛的市場地位，平衡短期商業性吸引力和長期永續性。

調查方法詳述了用於開發可操作和可複製見解的多模態方法

本分析整合了多模態研究途徑，結合了同行評審臨床文獻的系統綜述、公共監管提交和設備核准的分析以及臨床實驗室登記的綜合分析，以繪製證據庫的成熟度圖。主要研究包括對外科醫生、採購負責人、門診手術中心管理人員和臨床教育工作者的結構化訪談，以了解現實世界中採用該技術的促進因素和工作流程的限制。此外，還對來自設備登記、付款人政策聲明和外科協會指南的二次資料流進行了三角測量，以檢驗趨勢並識別證據缺口。

增強型市場情報透過產品級基準測試和比較技術評估進行增強，這些評估考察了設備設計、與手術平台的兼容性以及服務模式。供應鍊和關稅影響分析是基於物流數據和供應商揭露，並運用情境規劃來確定製造商和醫療保健提供者可用的營運槓桿。在整個研究過程中，我們應用了資料品管和交叉檢驗技術，以減少偏差並確保可重複性。我們承認，在公開資料稀缺或地區差異限制了普遍性的情況下，本研究有其限制。

結論：對整個生態系統相關人員的策略影響和未來方向的總結

減重手術器械產業正處於技術創新、不斷發展的護理環境和不斷變化的採購動態交匯的關鍵時刻。在這種環境下取得成功需要一種整體方法，將差異化器械性能與嚴謹的臨床證據、靈活的商業模式和富有彈性的供應鏈相結合。隨著門診規模的擴大以及機器人和內視鏡技術的成熟，那些優先考慮互通性、臨床醫生培訓和療效等提案主張的公司將擁有最清晰的持續應用路徑。

不斷變化的關稅和區域差異凸顯了靈活的籌資策略和區域市場規劃的重要性。相關人員應在短期營運需求與長期證據和平台開發投資之間取得平衡。透過使產品設計與最終用戶工作流程和付款人期望相一致，並建立能夠產生高品質真實世界數據的臨床醫生夥伴關係關係，行業參與者可以將新興趨勢轉化為永續的競爭優勢並改善患者治療效果。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 機器人輔助腹腔鏡器械在複雜性袖狀切除術的應用日益增多
  • 開發生物可吸收胃植入，旨在最大程度降低慢性異物反應的風險
  • 擴大內視鏡經口袖狀胃成形術裝置，實現門診病人減重減重
  • 整合感測器的胃內球囊，用於即時監測胃內壓力和容量
  • 結合機械限制和肽激素輸送功能的雙功能胃內球囊的出現
  • 3D 列印患者專用胃束帶和支架可最佳化貼合度並降低併發症率
  • 使用遠端醫療連接的穿戴式監測系統來追蹤術後體重減輕和營養依從性

第6章 2025年美國關稅的累積影響

第7章 人工智慧的累積影響，2025年

8. 減重手術器械市場（依手術類型）

  • 可調式胃束帶手術
  • 胃繞道手術
  • 袖狀切除術

9. 減重手術設備市場（依設備類型）

  • 切割和裝訂設備
  • 內視鏡設備
    • 裝訂設備
    • 縫合器
  • 植入
    • 樂隊系統
    • 港口系統
  • 視覺化系統

第 10 章減肥手術設備市場（按技術）

  • 腹腔鏡
  • 打開
  • 機器人
    • 多臂
    • 單埠

第 11 章減重手術設備市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 專科診所

第12章 減重手術器械市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 減肥手術器械市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國減肥手術器械市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Johnson & Johnson
    • Medtronic plc
    • Becton, Dickinson and Company
    • Intuitive Surgical, Inc.
    • Stryker Corporation
    • Olympus Corporation
    • Smith & Nephew plc
    • CONMED Corporation
    • Boston Scientific Corporation
    • Teleflex Incorporated
Product Code: MRR-036C5CF3A89F

The Obesity Surgery Devices Market is projected to grow by USD 8.22 billion at a CAGR of 8.15% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.39 billion
Estimated Year [2025] USD 4.75 billion
Forecast Year [2032] USD 8.22 billion
CAGR (%) 8.15%

A Comprehensive Introduction Framing the Current State and Strategic Imperatives for Obesity Surgery Devices

The obesity surgery devices landscape sits at the intersection of clinical necessity, accelerating technology adoption, and evolving care delivery models. Over the past decade clinicians and device developers have navigated a shifting set of priorities: improving operative safety and outcomes, reducing procedure times, and expanding access to ambulatory settings. These drivers coalesce with patient demand for less invasive options and payers' increasing focus on long-term cost containment, requiring device strategies that offer clear clinical differentiation alongside pragmatic value propositions.

Clinical pathways are maturing as bariatric care integrates multidisciplinary preoperative optimization and long-term metabolic follow-up. Consequently, device design priorities have transitioned from mere procedural enablement to end-to-end care support, emphasizing ergonomics, compatibility with evolving surgical platforms, and seamless incorporation into hospital and ambulatory workflows. Concurrently, regulatory scrutiny and heightened expectations for real-world evidence are prompting developers to invest in more robust clinical programs and longitudinal outcome tracking.

Taken together, this environment rewards companies that can demonstrate both clinical efficacy and operational efficiency, while also managing supply chain resilience and reimbursement complexity. As stakeholders plan product roadmaps and commercialization strategies, they must balance near-term adoption levers against longer-term investments in evidence generation and platform interoperability.

Transformative Shifts Redefining Competitive Advantage and Clinical Pathways in Obesity Surgery Devices

The past several years have produced transformative shifts that are redefining competitive advantage across the device landscape. Robotics and advanced visualization systems have moved from adjunct tools to core platforms that change how procedures are planned and executed. Enhanced endoscopic approaches, including expanded stapling and suturing capabilities, are enabling less invasive interventions and opening new pathways for patients who previously faced limited options. These technology shifts are compounded by improvements in implant materials and port systems that aim to reduce complication rates and streamline revision procedures.

Simultaneously, care delivery models are evolving as surgeries migrate into ambulatory surgical centers and specialty clinics where feasible, driven by shorter stays, optimized perioperative pathways, and payer incentives for lower-cost settings. This shift requires devices that are facile for smaller teams, compatible with limited infrastructure, and supported by efficient supply chain and sterilization workflows. Payer and policy landscapes are also influencing device adoption; value-based procurement models increasingly prioritize demonstrable outcomes, driving developers to align clinical evidence strategies with economic endpoints.

Innovation is no longer exclusively about the device itself but also about the ecosystem around it. Digital health integration, remote monitoring, and data-driven patient selection are becoming essential complements to hardware advances. For industry players, the strategic priority is to integrate these elements into cohesive solutions that improve patient outcomes, reduce total episode costs, and support scalable adoption across diverse care settings.

Cumulative Effects of United States Tariff Changes in 2025 on Supply Chains Commercial Strategy and Clinical Adoption Dynamics

The introduction of new or higher tariffs in the United States during 2025 has introduced discrete and cumulative effects across the obesity surgery devices ecosystem. Manufacturers that historically sourced components or finished goods from international suppliers faced increased landed costs, prompting rapid reassessments of sourcing strategies. In response, several firms accelerated supplier diversification, established regional distribution centers, and intensified negotiations to mitigate margin erosion. These operational responses have repercussions for lead times, inventory strategies, and capital allocation decisions.

Procurement teams within hospitals and ambulatory surgical centers reacted to tariff-driven cost pressures by reassessing purchasing agreements and prioritizing devices that deliver clear operational savings or lower complication rates. As a result, device suppliers with robust value dossiers and total-cost-of-care evidence secured preferred positions with system-level purchasing organizations, while products lacking differentiated clinical or economic value encountered adoption headwinds. Over time, device lifecycles and upgrade cadences shifted as customers deferred nonessential acquisitions in favor of maintaining core capabilities.

Tariffs also altered the competitive landscape by lowering the relative advantage of some low-cost foreign entrants and by creating incentives for regional manufacturing investments. Regulatory and compliance workloads increased as firms navigated customs classifications and documentation. Looking forward, companies are likely to continue investing in localized manufacturing capability and in contractual structures that share tariff risk with distribution partners, while payers and providers emphasize procurement flexibility and supplier resilience.

Key Segmentation Insights Illuminating Device and Procedure-Specific Opportunities and Differentiation Strategies

Segmenting the opportunity set reveals meaningful differences in clinical needs, procurement cycles, and innovation priorities. When considering procedure type across adjustable gastric banding, gastric bypass, and sleeve gastrectomy, device requirements diverge: adjustable gastric banding emphasizes implant longevity and port system reliability, gastric bypass places higher emphasis on complex stapling and anastomosis integrity, and sleeve gastrectomy demands durable stapling platforms and consistent stapler performance under variable tissue conditions. These distinctions influence product development priorities and post-market surveillance strategies.

Exploring device type segmentation illuminates how cutting and stapling devices, endoscopic devices, implants, and visualization systems each command distinct clinical and commercial playbooks. Within endoscopic devices, the subdomains of stapling devices and suturing devices present separate adoption trajectories driven by clinician skillsets and procedural workflows. Similarly, implant categories such as band systems and port systems require sustained attention to biocompatibility, infection prevention, and explant logistics, shaping after-market services and warranty structures.

Technology segmentation across laparoscopic, open, and robotic approaches highlights divergent capital and training requirements. Robotic solutions-whether multi-arm or single-port configurations-often involve higher upfront investment and longer onboarding curves but can enable greater precision and novel procedural approaches. Finally, end-user segmentation spanning ambulatory surgical centers, hospitals, and specialty clinics, with hospitals further differentiated into private and public institutions, dictates differing procurement cycles, purchasing authority, and operational constraints. Ambulatory settings demand efficient turnover and streamlined sterilization, private hospitals may prioritize premium platforms that support broader service lines, and public hospitals often emphasize cost-effectiveness and standardization. These layered segmentations are essential for tailoring clinical evidence, pricing, and go-to-market strategies that align with the needs of each stakeholder group.

Regional Insights Highlighting Varied Adoption Pathways and Strategic Priorities across Global Markets

Regional dynamics continue to shape investment priorities and adoption patterns across the obesity surgery devices landscape. In the Americas, established hospital systems and a mature private-pay environment support rapid uptake of advanced visualization and robotic platforms, while ambulatory surgical centers expand the addressable population by enabling efficient scheduling and shorter patient stays. Partnerships between device suppliers and large integrated delivery networks are increasingly important for piloting new technologies and collecting real-world evidence.

In Europe, Middle East & Africa, regional heterogeneity is pronounced. Western European systems often emphasize rigorous health technology assessment and cost-effectiveness, requiring robust clinical and economic dossiers for reimbursement and system-level adoption. Middle Eastern markets present opportunities for rapid capital investment and center-of-excellence development, whereas parts of Africa remain constrained by infrastructure and workforce limitations, creating a focus on durable, low-maintenance solutions that can function in resource-limited settings.

Asia-Pacific markets are characterized by a mix of rapid surgical volume growth, varying regulatory pathways, and significant investment in robotic and minimally invasive platforms. Several countries in the region are building surgical capacity in tertiary centers and expanding training programs that support complex procedures. Across all regions, supply chain resilience, localized regulatory strategies, and culturally informed patient engagement are critical to successful product introductions and sustained adoption.

Key Companies Insights Emphasizing Strategic Positioning Technology Focus and Collaboration Imperatives

Industry participants vary widely in strategic orientation, with established medical device leaders focusing on integrated platform development and regulatory-grade evidence generation, while innovative challengers concentrate on niche technological advantages such as novel stapling mechanics, suturing modalities, or single-port robotic solutions. Competitive differentiation increasingly depends on the ability to bundle hardware with services, clinical training, and data analytics that demonstrate improved outcomes and streamlined perioperative workflows.

Collaborations between device developers, robotic platform providers, and clinical centers of excellence are accelerating clinical adoption by addressing both technical and training barriers. Licensing arrangements, co-development partnerships, and service contracts enable faster market entry for specialized devices while sharing development risk. Additionally, companies investing in comprehensive post-market surveillance and real-world evidence collection are better positioned to respond to payer demands and to secure preferred provider agreements.

Manufacturers that prioritize modularity and interoperability across visualization, stapling, and endoscopic systems are gaining traction with hospital systems seeking long-term capital efficiency. Meanwhile, firms that excel at nimble regulatory navigation and localized market entry strategies are capturing opportunities in rapidly growing regions. For all participants, aligning product roadmaps with clinician workflows and procurement realities remains the most consistent predictor of durable adoption.

Actionable Recommendations for Industry Leaders to Translate Insight into Commercial and Clinical Advantage

First, prioritize investments in clinical evidence that tie device performance to relevant patient-centric and episode-level outcomes; robust longitudinal data will be critical for negotiations with payers and large provider systems. Second, design devices and commercial models with ambulatory adoption in mind, ensuring ease of use, rapid turnover, and minimal ancillary infrastructure requirements to appeal to ambulatory surgical centers and specialty clinics. Third, fortify supply chain resilience by diversifying suppliers, establishing regional inventory buffers, and exploring localized manufacturing or assembly to mitigate tariff and logistics risk.

Fourth, pursue interoperability and modularity, enabling devices to integrate with prevailing visualization and robotic platforms, which lowers switching costs for customers and enhances cross-selling potential. Fifth, develop differentiated value propositions for distinct end users by tailoring training programs, warranty models, and service contracts to the needs of private hospitals, public hospitals, and outpatient settings. Sixth, engage proactively with payers and health technology assessment bodies to align evidence generation with reimbursement criteria and to explore innovative contracting approaches that share risk based on outcomes.

Finally, foster partnerships with clinical champions and centers of excellence to accelerate adoption, refine procedural protocols, and generate high-quality real-world data. These actions combined will create a defensible market position that balances near-term commercial traction with long-term sustainability.

Research Methodology Detailing the Multimodal Approach Used to Develop Actionable and Reproducible Insights

This analysis integrates a multimodal research approach combining systematic review of peer-reviewed clinical literature, analysis of public regulatory filings and device approvals, and synthesis of clinical trial registries to map evidence maturity. Primary qualitative research included structured interviews with surgeons, procurement leaders, ambulatory surgical center administrators, and clinical educators to capture real-world adoption drivers and workflow constraints. In addition, secondary data streams from device registries, payer policy statements, and surgical society guidelines were triangulated to validate trends and identify gaps in evidence.

Market-facing intelligence was augmented by product-level benchmarking and comparative technology assessments that examined device design, compatibility with surgical platforms, and service models. Supply chain and tariff impact analyses were informed by logistics data and supplier disclosures, with scenario planning used to surface operational levers available to manufacturers and providers. Throughout the research process, data quality controls and cross-validation techniques were applied to limit bias and ensure reproducibility. Limitations are acknowledged where public data are sparse or where regional variability constrains generalizability; in such cases, findings are framed as directional rather than definitive.

Conclusion Summarizing Strategic Implications and the Path Forward for Stakeholders Across the Ecosystem

The obesity surgery devices sector stands at a pivotal moment where technological innovation, evolving care settings, and shifting procurement dynamics intersect. Success in this environment requires a holistic approach that couples differentiated device performance with rigorous clinical evidence, adaptable commercial models, and resilient supply chains. As ambulatory settings expand and robotic and endoscopic capabilities mature, companies that prioritize interoperability, clinician training, and outcome-focused value propositions will capture the clearest pathways to sustained adoption.

Tariff shifts and regional heterogeneity underscore the importance of flexible sourcing strategies and localized market plans. Stakeholders should balance near-term operational needs with investments in long-term evidence and platform development. By aligning product design with end-user workflows and payer expectations, and by fostering clinician partnerships that generate high-quality real-world data, industry players can convert emerging trends into durable competitive advantage and improved patient care outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increased adoption of robotic-assisted laparoscopic instruments for complex sleeve gastrectomy procedures
  • 5.2. Development of bioresorbable gastric implants designed to minimize chronic foreign body reaction risks
  • 5.3. Expansion of endoscopic transoral sleeve gastroplasty devices enabling outpatient weight loss interventions
  • 5.4. Integration of sensor-enabled intragastric balloons for real-time monitoring of gastric pressure and volume
  • 5.5. Emergence of dual-function intragastric balloons combining mechanical restriction with peptide hormone delivery capabilities
  • 5.6. Adoption of 3D printing for patient-specific gastric bands and stents to optimize fit and reduce complication rates
  • 5.7. Use of telehealth-connected wearable monitoring systems to track postoperative weight loss and nutritional compliance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Obesity Surgery Devices Market, by Procedure Type

  • 8.1. Adjustable Gastric Banding
  • 8.2. Gastric Bypass
  • 8.3. Sleeve Gastrectomy

9. Obesity Surgery Devices Market, by Device Type

  • 9.1. Cutting And Stapling Devices
  • 9.2. Endoscopic Devices
    • 9.2.1. Stapling Devices
    • 9.2.2. Suturing Devices
  • 9.3. Implants
    • 9.3.1. Band Systems
    • 9.3.2. Port Systems
  • 9.4. Visualization Systems

10. Obesity Surgery Devices Market, by Technology

  • 10.1. Laparoscopic
  • 10.2. Open
  • 10.3. Robotic
    • 10.3.1. Multi Arm
    • 10.3.2. Single Port

11. Obesity Surgery Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
    • 11.2.1. Private Hospitals
    • 11.2.2. Public Hospitals
  • 11.3. Specialty Clinics

12. Obesity Surgery Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Obesity Surgery Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Obesity Surgery Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Johnson & Johnson
    • 15.3.2. Medtronic plc
    • 15.3.3. Becton, Dickinson and Company
    • 15.3.4. Intuitive Surgical, Inc.
    • 15.3.5. Stryker Corporation
    • 15.3.6. Olympus Corporation
    • 15.3.7. Smith & Nephew plc
    • 15.3.8. CONMED Corporation
    • 15.3.9. Boston Scientific Corporation
    • 15.3.10. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. OBESITY SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. OBESITY SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. OBESITY SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY CUTTING AND STAPLING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY CUTTING AND STAPLING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY CUTTING AND STAPLING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY CUTTING AND STAPLING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY CUTTING AND STAPLING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY CUTTING AND STAPLING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY STAPLING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY STAPLING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY STAPLING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY STAPLING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY STAPLING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY STAPLING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SUTURING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SUTURING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SUTURING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SUTURING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SUTURING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SUTURING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY BAND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY BAND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY BAND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY BAND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY BAND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY BAND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PORT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PORT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PORT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PORT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PORT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PORT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY OPEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY OPEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY OPEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY OPEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY OPEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MULTI ARM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MULTI ARM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MULTI ARM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MULTI ARM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MULTI ARM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MULTI ARM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SINGLE PORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SINGLE PORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SINGLE PORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SINGLE PORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SINGLE PORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SINGLE PORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 305. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 306. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 312. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 313. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 320. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY EN